A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
7 Hills Pharma, LLC
The Methodist Hospital Research Institute
OncoC4, Inc.
Pfizer
Genmab
Merck Sharp & Dohme LLC
USWM, LLC (dba US WorldMeds)
Seagen Inc.
KaliVir Immunotherapeutics
Pfizer
Wake Forest University Health Sciences
NRG Oncology
M.D. Anderson Cancer Center
Novartis
Pfizer
Institut Cancerologie de l'Ouest
Aulos Bioscience, Inc.
Bayer
iOnctura
Memorial Sloan Kettering Cancer Center
Sotio Biotech Inc.
Pfizer
Pfizer
Obsidian Therapeutics, Inc.
University of Zurich
National Cancer Institute (NCI)
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bayer
Brigham and Women's Hospital
Mayo Clinic
Hoffmann-La Roche
Dragonfly Therapeutics
M.D. Anderson Cancer Center
Dragonfly Therapeutics
Stanford University
AstraZeneca
Seagen Inc.
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
Mayo Clinic
BioNTech SE
University of California, Davis
Emory University